For the purpose of exploring the biology-wise significance of MATN3 in GC patients, our team analyzed the TCGA datasets and found that the expression of MATN3 was remarkably elevated in GC samples in contrast to noncancer samples (Figure 1(a)). The gene discussed is MATN3; the disease is gastric cancer.